Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

Why Abbott Stock Jumped Today

A recent acquisition is already bearing fruit.

Abbott Laboratories: Double Beat And Raise Surprises The Street (Rating Upgrade) (ABT)

Abbott Laboratories surged 14% after strong Q2 earnings and raised FY2026 guidance—see valuation, growth drivers and hold call. Click for this ABT stock update now.

Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised

Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outlook and reaffirmed revenue growth guidance. Progress across its medical devices and diagnostics pipeline further boosted investor confidence in future growth.

Abbott Laboratories Reports Q2 2026 Results: Full Earnings Call Transcript - Abbott Laboratories (NYSE:AB

Abbott Laboratories (NYSE:ABT) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts

Abbott posted stronger-than-expected profit and is raising its full-year earnings outlook

The healthcare company posted adjusted earnings of $1.31 a share in the second quarter, topping Wall Street's estimate of $1.28

Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2026....